These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 8600572)
1. Acquisition of multiple copies of a mutant topoisomerase IIalpha allele by chromosome 17 aneuploidy is associated with etoposide resistance in human melanoma cell lines. Campain JA; Slovak ML; Schoenlein PV; Popescu NC; Gottesman MM; Pastan I Somat Cell Mol Genet; 1995 Nov; 21(6):451-71. PubMed ID: 8600572 [TBL] [Abstract][Full Text] [Related]
2. A novel mutant topoisomerase II alpha present in VP-16-resistant human melanoma cell lines has a deletion of alanine 429. Campain JA; Gottesman MM; Pastan I Biochemistry; 1994 Sep; 33(37):11327-32. PubMed ID: 7727383 [TBL] [Abstract][Full Text] [Related]
3. Hypophosphorylation of topoisomerase IIalpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation. Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T Jpn J Cancer Res; 2001 Jul; 92(7):799-805. PubMed ID: 11473732 [TBL] [Abstract][Full Text] [Related]
4. Characterization of an unusual mutant of human melanoma cells resistant to anticancer drugs that inhibit topoisomerase II. Campain JA; Padmanabhan R; Hwang J; Gottesman MM; Pastan I J Cell Physiol; 1993 May; 155(2):414-25. PubMed ID: 8097746 [TBL] [Abstract][Full Text] [Related]
5. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines. Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249 [TBL] [Abstract][Full Text] [Related]
6. Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer. Järvinen TA; Tanner M; Rantanen V; Bärlund M; Borg A; Grénman S; Isola J Am J Pathol; 2000 Mar; 156(3):839-47. PubMed ID: 10702400 [TBL] [Abstract][Full Text] [Related]
7. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization. Wessel I; Jensen PB; Falck J; Mirski SE; Cole SP; Sehested M Cancer Res; 1997 Oct; 57(20):4451-4. PubMed ID: 9377550 [TBL] [Abstract][Full Text] [Related]
8. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors. Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406 [TBL] [Abstract][Full Text] [Related]
9. Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype. Matsumoto Y; Takano H; Fojo T Cancer Res; 1997 Nov; 57(22):5086-92. PubMed ID: 9371507 [TBL] [Abstract][Full Text] [Related]
10. Increased phosphorylation of DNA topoisomerase II in etoposide resistant mutants of human glioma cell line. Matsumoto Y; Kunishio K; Nagao S J Neurooncol; 1999; 45(1):37-46. PubMed ID: 10728908 [TBL] [Abstract][Full Text] [Related]
11. A truncated cytoplasmic topoisomerase IIalpha in a drug-resistant lung cancer cell line is encoded by a TOP2A allele with a partial deletion of exon 34. Mirski SE; Sparks KE; Yu Q; Lang AJ; Jain N; Campling BG; Cole SP Int J Cancer; 2000 Feb; 85(4):534-9. PubMed ID: 10699927 [TBL] [Abstract][Full Text] [Related]
12. Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells. Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T Jpn J Cancer Res; 2001 Jul; 92(7):778-84. PubMed ID: 11473729 [TBL] [Abstract][Full Text] [Related]
13. Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIalpha gene transfer is independent of topoisomerase IIbeta. Zhou Z; Zwelling LA; Ganapathi R; Kleinerman ES Br J Cancer; 2001 Sep; 85(5):747-51. PubMed ID: 11531262 [TBL] [Abstract][Full Text] [Related]
14. Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha. Patel S; Jazrawi E; Creighton AM; Austin CA; Fisher LM Mol Pharmacol; 2000 Sep; 58(3):560-8. PubMed ID: 10953049 [TBL] [Abstract][Full Text] [Related]
15. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin. Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812 [TBL] [Abstract][Full Text] [Related]
16. In vivo etoposide-resistant C6 glioma cell line: significance of altered DNA topoisomerase II activity in multi-drug resistance. Taki T; Ohnishi T; Arita N; Hiraga S; Hayakawa T J Neurooncol; 1998 Jan; 36(1):41-53. PubMed ID: 9525824 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells. Zhou Z; Zwelling LA; Kawakami Y; An T; Kobayashi K; Herzog C; Kleinerman ES Cancer Res; 1999 Sep; 59(18):4618-24. PubMed ID: 10493516 [TBL] [Abstract][Full Text] [Related]
18. Mutations at arg486 and glu571 in human topoisomerase IIalpha confer resistance to amsacrine: relevance for antitumor drug resistance in human cells. Patel S; Keller BA; Fisher LM Mol Pharmacol; 2000 Apr; 57(4):784-91. PubMed ID: 10727526 [TBL] [Abstract][Full Text] [Related]
19. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide. Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806 [TBL] [Abstract][Full Text] [Related]
20. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure. Matsumoto Y; Takano H; Nagao S; Fojo T Jpn J Cancer Res; 2001 Sep; 92(9):968-74. PubMed ID: 11572765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]